Global COVID-19 prevention trial of hydroxychloroquine to resume
Medical cannabis ETFs on cusp of mainstream breakthrough
Bharat Biotech begins trial of COVID-19 vaccine in India as cases mount
Coronavirus: the antibody drugs few people have been discussing – until now
Vaxart Oral COVID-19 Vaccine Joins Trump’s “Warp Speed,” Ramps Up Manufacturing Capacity
Existing drugs can prevent SARS-CoV-2 from hijacking cells
Coronavirus and cancer hijack the same parts in human cells to spread – and our team identified existing cancer drugs that could fight COVID-19
AstraZeneca, Moderna ahead in COVID-19 vaccine race: WHO
Inovio (INO) Stock Is a Winner, but Its Valuation Is Getting Stretched
Children more resilient against coronavirus, study reveals
Molecular Partners hopes for COVID-19 rebound after eye drug failure
COVID-19 drug remdesivir recommended for EU approval
One coronavirus vaccine stock is up 750% this year. Could the rest follow?
3 Biotech Stocks Under $5 With 100%-Plus Upside Potential
3 Under-the-Radar Penny Stocks Gearing up for Gains
Entos Pharmaceuticals announces selection of lead DNA vaccine candidates for COVID-19
Top Analysts See 100%-Plus Upside Potential in These 3 Penny Stocks
Top Analysts Bet on These 3 Penny Stocks; See 100%-Plus Upside Potential
COVID-19 and cancer: can pharma stymie the pandemic’s impact on mortality?
APT Doubles While Other Biotechs Take Off On Rising New Coronavirus Case Numbers
AstraZeneca taps Scottish firm for 10th COVID-19 vaccine supply deal
COVID-19: Bacteriophage could decrease mortality
Trial starts with Imperial College London coronavirus vaccine
ETFMG launches ‘infectious diseases’ biotech ETF
Nurturing A Culture Of “Smart Speed” To Bring Gene Therapy To The World
First COVID-19 vaccine trial in South Africa begins
Gilead targets two million remdesivir courses by year-end
Evoke Pharma Pops 86% In Pre-Market On FDA Approval Of Gimoti Nasal Spray
The right way to breathe during the coronavirus pandemic
UK team awarded grant for ‘second wave’ COVID-19 drug hunt